KOMBIGLYZE XR 1000 mg/1 (Saxagliptin and Metformin Hydrochloride TABLET, FILM COATED, EXTENDED RELEASE) 1000 mg/1

KOMBIGLYZE XR 1000 mg/1 combines saxagliptin and metformin hydrochloride for extended-release oral administration. This prescription medication is designed to help manage certain health conditions. Learn more about its uses and effects.

Strength

1000 mg/1

Pack Size

30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0310-6145-30)

Manufacturer / TM Owner

AstraZeneca Pharmaceuticals LP

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

KOMBIGLYZE XR 1000 mg/1 is a combination medication that includes saxagliptin and metformin hydrochloride. It is commonly used to help manage blood sugar levels in adults with type 2 diabetes. This extended-release tablet is designed to be taken once daily, providing a convenient option for those who need consistent medication support. Always consult a healthcare provider to determine if this medication is suitable for your specific needs.

Side Effects

Common effects of KOMBIGLYZE XR 1000 mg/1 may include gastrointestinal discomfort, such as nausea or diarrhea, especially when first starting the medication. Some users may also experience headaches or dizziness. These effects are generally mild and temporary, but if they persist or worsen, it is important to seek medical advice.

Precautions & Warnings

KOMBIGLYZE XR 1000 mg/1 should be handled with care. Store the medication at room temperature, away from moisture and heat. It is important to follow the prescribed dosage and administration instructions provided by your healthcare provider. Do not crush or chew the extended-release tablets, as this can affect their effectiveness.

Avoid Interactions

KOMBIGLYZE XR 1000 mg/1 may interact with certain medications, including other diabetes drugs, blood pressure medications, and some antibiotics. It is important to inform your healthcare provider about all the medications you are taking to avoid potential interactions. Additionally, alcohol consumption should be limited while using this medication, as it can increase the risk of side effects.

Frequently Asked Questions

KOMBIGLYZE XR 1000 mg/1 is used to help manage blood sugar levels in adults with type 2 diabetes.

KOMBIGLYZE XR 1000 mg/1 is typically taken once daily with a meal, as directed by your healthcare provider.

Common side effects may include gastrointestinal discomfort, headaches, and dizziness.

It is advisable to limit alcohol consumption while taking KOMBIGLYZE XR 1000 mg/1, as it can increase the risk of side effects.

If you miss a dose, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and continue with your regular schedule.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.